CATALOGO DEI PRODOTTI DELLA RICERCA

DONADELLI, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.449
EU - Europa 6.256
AS - Asia 4.341
SA - Sud America 620
AF - Africa 116
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 4
Totale 17.800
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.295
RU - Federazione Russa 2.457
SG - Singapore 1.608
CN - Cina 1.277
GB - Regno Unito 1.268
IT - Italia 789
BR - Brasile 496
VN - Vietnam 484
HK - Hong Kong 368
DE - Germania 339
FR - Francia 310
SE - Svezia 284
IE - Irlanda 242
FI - Finlandia 228
KR - Corea 142
IN - India 79
CA - Canada 78
UA - Ucraina 72
ID - Indonesia 68
TR - Turchia 60
NL - Olanda 57
BD - Bangladesh 56
MX - Messico 55
JP - Giappone 49
AR - Argentina 47
ES - Italia 43
PL - Polonia 39
BE - Belgio 38
AT - Austria 24
ZA - Sudafrica 22
NG - Nigeria 21
EC - Ecuador 19
IQ - Iraq 19
SA - Arabia Saudita 18
CO - Colombia 15
IR - Iran 15
BJ - Benin 14
MY - Malesia 12
PK - Pakistan 12
UZ - Uzbekistan 12
PH - Filippine 11
VE - Venezuela 11
AU - Australia 10
LT - Lituania 10
MA - Marocco 10
CL - Cile 9
PE - Perù 9
TG - Togo 9
RO - Romania 7
CH - Svizzera 6
DZ - Algeria 6
IL - Israele 6
NP - Nepal 6
TN - Tunisia 6
BO - Bolivia 5
JO - Giordania 5
KE - Kenya 5
PY - Paraguay 5
AL - Albania 4
EG - Egitto 4
JM - Giamaica 4
KZ - Kazakistan 4
NO - Norvegia 4
TH - Thailandia 4
UY - Uruguay 4
BG - Bulgaria 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
GA - Gabon 3
GR - Grecia 3
HR - Croazia 3
HU - Ungheria 3
KW - Kuwait 3
MM - Myanmar 3
OM - Oman 3
PS - Palestinian Territory 3
PT - Portogallo 3
TZ - Tanzania 3
XK - ???statistics.table.value.countryCode.XK??? 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
DO - Repubblica Dominicana 2
EE - Estonia 2
HN - Honduras 2
KG - Kirghizistan 2
LB - Libano 2
ML - Mali 2
MT - Malta 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AG - Antigua e Barbuda 1
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
Totale 17.775
Salva come PNG Salva come JPEG
Città #
Southend 1.082
Moscow 879
Singapore 829
Ashburn 746
Dallas 682
Chandler 676
San Jose 590
Verona 376
Jacksonville 363
Hong Kong 362
Woodbridge 328
Ann Arbor 302
Beijing 243
Dublin 240
New York 201
The Dalles 183
Houston 154
Ho Chi Minh City 145
Los Angeles 119
Munich 99
Hanoi 98
Lawrence 93
Princeton 93
Wilmington 89
Nanjing 75
Council Bluffs 71
Jinan 70
Redmond 70
Helsinki 62
Shenyang 62
Tianjin 57
Phoenix 56
São Paulo 56
Buffalo 49
Jakarta 49
Columbus 48
Hebei 48
Dong Ket 45
Redondo Beach 44
Milan 43
Tokyo 41
London 39
Orem 39
Changsha 36
Brussels 35
Redwood City 34
Seoul 33
Sindelfingen 33
Turku 33
Frankfurt am Main 32
Lappeenranta 32
Venice 32
Zhengzhou 32
Santa Clara 31
Haikou 30
Nanchang 28
Warsaw 28
Montreal 27
Düsseldorf 24
Seattle 24
Guangzhou 23
Ningbo 23
Boardman 22
Brooklyn 22
Hangzhou 21
Jiaxing 21
Mexico City 21
Norwalk 21
Rio de Janeiro 21
Stockholm 21
Chicago 20
Haiphong 20
Toronto 20
Boston 18
Chennai 18
Manchester 18
Amsterdam 17
Atlanta 17
Da Nang 17
Kent 17
Abuja 16
Madrid 16
Taizhou 16
Nuremberg 15
Poplar 15
San Francisco 15
Cotonou 14
Johannesburg 14
Augusta 13
Taiyuan 13
Caserta 12
Vienna 12
Denver 11
Dhaka 11
Querétaro 11
Washington 11
Fuzhou 10
Tashkent 10
Auburn Hills 9
Baghdad 9
Totale 11.171
Salva come PNG Salva come JPEG
Nome #
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism 344
Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis 301
Gemcitabine response in pancreatic adenocarcinoma cells is synergistically enhanced by dithiocarbamate derivatives 296
Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survival 258
ISOLATION AND DRUG SENSITIVITY OF CANCER STEM CELLS OBTAINED FROM PANCREATIC ADENOCARCINOMA CELL LINES 246
Cytotoxicity of Polyspermine-Ribonuclease A and Polyspermine-Dimeric Ribonuclease A 239
Activation of the Interleukin-6 promoter by a dominant negative mutant of c-Jun 235
Autophagy induced by p53-reactivating molecules protects pancreatic cancer cells from apoptosis. 234
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 229
Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells. 225
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 224
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 216
Intracellular zinc increase inhibits p53(-/-) pancreatic adenocarcinoma cell growth by ROS/AIF-mediated apoptosis 213
B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression 211
Role of mitochondrial uncoupling protein-2 in cancer cell resistance to gemcitabine 208
REDOX SIGNALING HYPERSENSITIVITY DISTINGUISHES CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH FAVORABLE PROGNOSIS 208
Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells 207
Bovine seminal ribonuclease triggers Beclin1-mediated autophagic cell death in pancreatic cancer cells 206
Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists 205
Antioxidant Mechanisms and ROS-Related MicroRNAs in Cancer Stem Cells 202
Gain-of-function mutant p53 enhances mitochondrial ROS through the inhibition of PGC-1α/UCP2 axis in cancer cells 202
Pancreatic endocrine tumours, a proteomic investigation of the trichostatin-A antitumoral effect 201
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 201
Cell communication and signaling: how to turn bad language into positive one 200
UCP2 inhibition triggers ROS-dependent nuclear translocation of GAPDH and autophagic cell death in pancreatic adenocarcinoma cells 197
Hyaluronic acid-coated liposomes for active targeting of gemcitabine 197
The rs1001179 SNP and CpG methylation regulate catalase expression in chronic lymphocytic leukemia 192
Proteomics in pancreatic cancer research. 191
Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition 191
Regulation of miR-23b expression and its dual role on ROS production and tumour development 189
Browsing the oldest antioxidant enzyme: catalase and its multiple regulation in cancer 189
Low catalase expression confers redox hypersensitivity and identifies an indolent clinical behavior in CLL 187
Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O2-· production in cancer cells 185
HUMAN T-LYMPHOBLASTIC LEUKAEMIA CELLS PRODUCE IL-8 IN RESPONSE TOCXCL12 SECRETED BY NORMAL BONE MARROW STROMA 184
Effects of CD20 antibodies and kinase inhibitors on B-cell receptor signalling and survival of chronic lymphocytic leukaemia cells 176
MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines 174
Double Domain Swapping in Bovine Seminal RNase: Formation of Distinct N- and C-swapped Tetramers and Multimers with Increasing Biological Activities 174
Onconase induces autophagy sensitizing pancreatic cancer cells to gemcitabine and activates Akt/mTOR pathway in a ROS-dependent manner 173
A comparison study on RNase A oligomerization induced by cisplatin, carboplatin and oxaliplatin 171
Increase of RNase A N-terminus Polarity or C-terminus Apolarity Changes the Two Domains' Propensity To Swap and Form the Two Dimeric Conformers of the Protein 169
UCP2, a mitochondrial protein regulated at multiple levels 169
Mitochondrial uncoupling protein-2 inhibition promotes gemcitabine response in cancer cells. 169
Onconase Dimerization Through 3D Domain Swapping: Structural Investigations and Increase Of The Apoptotic Effect In Cancer Cells 169
Identification of a candidate alternative promoter region of the human Bcl2L11 (Bim) gene 168
Regulation of autophagy by nuclear GAPDH and its aggregates in cancer and neurodegenerative disorders 168
Oncometabolites in cancer aggressiveness and tumour repopulation 165
Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine 163
3-Bromo-Isoxazoline Derivatives Inhibit GAPDH Enzyme in PDAC Cells Triggering Autophagy and Apoptotic Cell Death 162
Mutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine 160
Mutant p53 and mTOR/PKM2 regulation in cancer cells 160
Gut microbiota modulates seizure susceptibility 160
UCP2 inhibition induces ROS/Akt/mTOR axis: role of GAPDH nuclear translocation in genipin/everolimus anticancer synergism 159
Mutant p53-Associated Molecular Mechanisms of ROS Regulation in Cancer Cells 158
Rehabilitation and biomarkers of stroke recovery: study protocol for a randomized controlled trial 157
Mutant p53 affects the mitochondrial proteome, promoting mitochondrial fragmentation and OXPHOS in pancreatic ductal adenocarcinoma cells 156
The antioxidant uncoupling protein 2 stimulates hnRNPA2/B1, GLUT1 and PKM2 expression and sensitizes pancreas cancer cells to glycolysis inhibition 156
Extracellular matrix composition modulates the responsiveness of differentiated and stem pancreatic cancer cells to lipophilic derivate of gemcitabine 156
Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2'-deoxycytidine treatment is associated with activation of the interferon signalling pathway 155
The antioxidant mitochondrial protein UCP2 promotes cancer development connecting theWarburg effect and autophagy 155
Mutant p53 induces SIRT3/MnSOD axis to moderate ROS production in melanoma cells 154
The metabolic landscape of cancer stem cells 151
Autocrine mechanisms of cancer chemoresistance 151
Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation. 148
Zinc depletion efficiently inhibits pancreatic cancer cell growth by increasing the ratio of antiproliferative/proliferative genes. 146
Mutant p53 proteins alter cancer cell secretome and tumour microenvironment: involvement in cancer invasion and metastasis 145
Bone marrow stromal cells up-regulate interleukin 8 production in human T-lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-κB and JNK/AP-1 pathways 143
Molecular interplay between mutant p53 proteins and autophagy in cancer cells 139
Sestrins at the Interface of ROS Control and Autophagy Regulation in Health and Disease 139
Targeting survival signaling pathways in chronic lymphocytic leukemia via anti-CD20 antibodies 137
CAT rs1001179 Single Nucleotide Polymorphism Identifies an Aggressive Clinical Behavior in Chronic Lymphocytic Leukemia 136
Sex differences in neuromuscular and biological determinants of isometric maximal force 135
ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma 135
The mutant p53-driven secretome has oncogenic functions in pancreatic ductal adenocarcinoma cells 129
Proteomic analysis of pancreatic ductal carcinoma cells treated with 5-aza-2'-deoxycytidine 127
Tumor Suppressor Role of Wild-Type P53-Dependent Secretome and Its Proteomic Identification in PDAC 127
MRP5 nitration by NO-releasing gemcitabine encapsulated in liposomes confers sensitivity in chemoresistant pancreatic adenocarcinoma cells 126
Mutant p53 prevents GAPDH nuclear translocation in pancreatic cancer cells favoring glycolysis and 2-deoxyglucose sensitivity 126
Synergistic effect of trichostatin A and 5-aza-2'-deoxycytidine on growth inhibition of pancreatic endocrine tumour cell lines: a proteomic study. 125
Interplay between ROS and Autophagy in Cancer and Aging: From Molecular Mechanisms to Novel Therapeutic Approaches 124
Prolonged exposure to simulated microgravity promotes stemness impairing morphological, metabolic and migratory profile of pancreatic cancer cells: a comprehensive proteomic, lipidomic and transcriptomic analysis 124
Proteomic analysis of pancreatic ductal carcinoma cells after combined treatment with gemcitabine and trichostatin A 123
Morphologic Characterization of Pancreatic Ductal Adenocarcinoma following Post-neoadjuvant Pancreatectomy and Clinical value of Intratumor Heterogeneity 122
Redox sensitive cysteine residues as crucial regulators of wild-type and mutant p53 isoforms 122
Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity 119
null 119
Sestrins as a therapeutic bridge between ROS and autophagy in cancer 119
Trichostatin A alters cytoskeleton and energy metabolism of pancreatic adenocarcinoma cells: an in depth proteomic study 117
Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity against pancreatic cancer cells 115
Mitochondrial uncoupling protein 2 and pancreatic cancer: a new potential target therapy 115
Regulation of succinate dehydrogenase and role of succinate in cancer 115
Proteomic Signature of PDAC Cells with Mutant p53 113
Fatty pancreas disease: an integrated study on frozen tissues shows distinct compartments of inter/intra-lobular, intra-acinar, and intra-islet fat deposition 112
To metabolomics and beyond: a technological portfolio to investigate cancer metabolism 111
“Proteomic profiling of pancreatic ductal carcinoma cell lines treated with trichostatin-A” 108
Proteomic analysis of pancreatic endocrine tumor cell lines treated with the histone deacetylase inhibitor trichostatin A. 103
Roles for microRNA 23b in regulating autophagy and development of pancreatic adenocarcinoma 102
Reprogramming tumor-immune cell interface in solid and hematological malignancies to enhance response to therapy 102
Hypoxia dictates metabolic rewiring of tumors: implications for chemoresistance 98
Increased stability of P21(WAF1/CIP1) mRNA is required for ROS/ERK-dependent pancreatic adenocarcinoma cell growth inhibition by pyrrolidine dithiocarbamate 97
Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells 94
Totale 16.608
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.855
article - articoli 51.995
book - libri 0
conference - conferenze 4.860
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.710
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021219 0 0 0 0 0 0 0 0 0 10 106 103
2021/2022815 114 200 20 53 21 19 26 52 25 29 71 185
2022/20231.867 121 196 154 364 158 418 23 98 206 61 50 18
2023/2024940 37 56 74 92 116 217 29 78 15 48 132 46
2024/20252.431 112 153 90 398 129 74 113 142 411 159 206 444
2025/20268.141 559 532 672 1.267 2.296 519 675 468 672 481 0 0
Totale 17.985